These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

160 related items for PubMed ID: 2646546

  • 1. [Current studies of the effects of immunosuppressive agents on multiple sclerosis].
    Minderhoud JM.
    Ned Tijdschr Geneeskd; 1989 Jan 21; 133(3):99-100. PubMed ID: 2646546
    [No Abstract] [Full Text] [Related]

  • 2. Therapeutic trials for multiple sclerosis.
    McKhann GM.
    Ann Neurol; 1990 Jun 21; 27(6):589-90. PubMed ID: 2193612
    [No Abstract] [Full Text] [Related]

  • 3. [Long-term therapeutic trials and multiple sclerosis: a wager?].
    Confavreux C.
    Rev Neurol (Paris); 1983 Jun 21; 139(6-7):431-7. PubMed ID: 6412341
    [No Abstract] [Full Text] [Related]

  • 4. Azathioprine and methotrexate in multiple sclerosis.
    Fernández O, Fernández V, De Ramón E.
    J Neurol Sci; 2004 Aug 15; 223(1):29-34. PubMed ID: 15261557
    [Abstract] [Full Text] [Related]

  • 5. [Immunosuppressive therapy of multiple sclerosis using cyclosporin A and azathioprine. Long-term effects, risks, proton spin tomography and immunological findings].
    Kappos L.
    Schriftenr Neurol; 1990 Aug 15; 32():1-200. PubMed ID: 2200108
    [No Abstract] [Full Text] [Related]

  • 6. [Immunosuppressive treatment im multiple sclerosis].
    Mertin J.
    Fortschr Med; 1980 Oct 02; 98(37):1431-6. PubMed ID: 6253370
    [Abstract] [Full Text] [Related]

  • 7. [Multiple sclerosis--current status of therapy].
    Reichel D, Kölmel HW.
    Z Arztl Fortbild (Jena); 1995 May 02; 89(2):151-8. PubMed ID: 7610682
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Immunosuppressive medication in multiple sclerosis].
    García Merino JA.
    Rev Neurol; 1995 May 02; 35(12):1154-8. PubMed ID: 12497298
    [Abstract] [Full Text] [Related]

  • 15. Current disease-modifying therapies in multiple sclerosis.
    Kieseier BC, Hartung HP.
    Semin Neurol; 2003 Jun 02; 23(2):133-46. PubMed ID: 12894379
    [Abstract] [Full Text] [Related]

  • 16. [Intensive immunosuppressive treatment of chronic progressive multiple sclerosis].
    Hommes OR.
    Ned Tijdschr Geneeskd; 1978 Oct 14; 122(41):1545-51. PubMed ID: 358004
    [No Abstract] [Full Text] [Related]

  • 17. Treatment of multiple sclerosis and other autoimmune diseases with cladribine.
    Beutler E, Sipe J, Romine J, McMillan R, Zyroff J, Koziol J.
    Semin Hematol; 1996 Jan 14; 33(1 Suppl 1):45-52. PubMed ID: 8714617
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Role of steroids and immunosuppression and effects of interferon beta-1b in multiple sclerosis.
    Goodkin DE.
    West J Med; 1994 Sep 14; 161(3):292-8. PubMed ID: 7975569
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.